New Risk • Mar 03
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥14.7b (US$93.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). Earnings have declined by 17% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (JP¥14.7b market cap, or US$93.3m). New Risk • Nov 04
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥15.3b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (JP¥15.3b market cap, or US$99.9m). Ankündigung • Aug 08
CanBas Co., Ltd., Annual General Meeting, Sep 29, 2025 CanBas Co., Ltd., Annual General Meeting, Sep 29, 2025. Ankündigung • Jun 03
CanBas Co., Ltd. to Report Fiscal Year 2025 Results on Aug 08, 2025 CanBas Co., Ltd. announced that they will report fiscal year 2025 results on Aug 08, 2025 New Risk • Apr 07
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥14.2b (US$97.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (JP¥14.2b market cap, or US$97.1m). Ankündigung • Aug 09
CanBas Co., Ltd., Annual General Meeting, Sep 27, 2024 CanBas Co., Ltd., Annual General Meeting, Sep 27, 2024. Ankündigung • Jun 05
CanBas Co., Ltd. to Report Fiscal Year 2024 Results on Aug 09, 2024 CanBas Co., Ltd. announced that they will report fiscal year 2024 results on Aug 09, 2024 New Risk • Feb 01
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: JP¥14.7b (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (5.8% average weekly change). Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (JP¥14.7b market cap, or US$99.8m). New Risk • Oct 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.4b free cash flow). Share price has been highly volatile over the past 3 months (7.4% average weekly change). Earnings have declined by 18% per year over the past 5 years. Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (24% increase in shares outstanding). New Risk • Aug 24
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.4b free cash flow). Share price has been highly volatile over the past 3 months (7.5% average weekly change). Earnings have declined by 18% per year over the past 5 years. Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Revenue is less than US$1m. New Risk • Aug 17
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -JP¥1.4b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-JP¥1.4b free cash flow). Earnings have declined by 18% per year over the past 5 years. Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (7.3% average weekly change). Ankündigung • Aug 12
CanBas Co., Ltd., Annual General Meeting, Sep 26, 2023 CanBas Co., Ltd., Annual General Meeting, Sep 26, 2023. New Risk • Aug 07
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 15% per year over the past 5 years. Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change). Ankündigung • May 20
CanBas Co., Ltd. announced that it expects to receive ¥729 million in funding CanBas Co., Ltd. announced a private placement of 500,000 common shares at an issue price of ¥1,458 per share for the gross proceeds of ¥729,000,000 on May 18, 2023. The transaction will include participation from new investors Long Corridor Alpha Opportunities Master Fund and MAP246 Segregated Portfolio. The company will issue shares through third-party allotment. The transaction has been approved by the board of directors of the company. The transaction is expected to close on June 2, 2023. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. 2 independent directors (5 non-independent directors). Independent External Director Toshio Furuta was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 15
Full year 2022 earnings released: JP¥88.26 loss per share (vs JP¥70.01 loss in FY 2021) Full year 2022 results: JP¥88.26 loss per share (down from JP¥70.01 loss in FY 2021). Net loss: JP¥855.0m (loss widened 61% from FY 2021). Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Ankündigung • Aug 14
CanBas Co., Ltd., Annual General Meeting, Sep 27, 2022 CanBas Co., Ltd., Annual General Meeting, Sep 27, 2022. Ankündigung • Jun 03
CanBas Co., Ltd. to Report Fiscal Year 2022 Results on Aug 12, 2022 CanBas Co., Ltd. announced that they will report fiscal year 2022 results on Aug 12, 2022 Reported Earnings • May 19
Third quarter 2022 earnings released: JP¥22.78 loss per share (vs JP¥9.24 loss in 3Q 2021) Third quarter 2022 results: JP¥22.78 loss per share (down from JP¥9.24 loss in 3Q 2021). Net loss: JP¥224.0m (loss widened 215% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 3 highly experienced directors. 2 independent directors (5 non-independent directors). Independent External Director Toshio Furuta was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Feb 12
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: JP¥39.87 loss per share (up from JP¥43.73 loss in 1H 2021). Net loss: JP¥359.0m (loss widened 16% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 12
First quarter 2022 earnings released: JP¥22.38 loss per share (vs JP¥29.76 loss in 1Q 2021) First quarter 2022 results: Net loss: JP¥198.0m (loss narrowed 5.7% from 1Q 2021). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Ankündigung • Sep 03
CanBas Co., Ltd. announced that it expects to receive ¥16.38843 million in funding CanBas Co., Ltd. announced a private placement of 55,554 units at a price of ¥295 for gross proceeds of ¥16,388,430 on September 2, 2021. The company has issued through 17th Stock Acquisition Rights. As part of the transaction, no monetary payment is required in exchange for the bonds with Stock Acquisition Rights. Reported Earnings • May 17
Third quarter 2021 earnings released: JP¥9.24 loss per share (vs JP¥19.46 loss in 3Q 2020) The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were flat. Third quarter 2021 results: Revenue: JP¥27.0m (flat on 3Q 2020). Net loss: JP¥71.0m (loss narrowed 47% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 14
Second quarter 2021 earnings released: JP¥14.04 loss per share (vs JP¥18.59 loss in 2Q 2020) The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were flat. Second quarter 2021 results: Revenue: JP¥28.0m (flat on 2Q 2020). Net loss: JP¥100.0m (loss narrowed 21% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Jan 05
New 90-day low: JP¥426 The company is down 40% from its price of JP¥710 on 07 October 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 11% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: JP¥457 The company is down 35% from its price of JP¥703 on 17 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 2.0% over the same period. Ankündigung • Nov 06
CanBas Co., Ltd. announced that it expects to receive ¥9.678321 million in funding from Advantage Partners, Inc. and other investors CanBas Co., Ltd. (TSE:4575) announced that it will issue 17,629 16th Stock Acquisition Rights at a price of ¥549 per stock acquisition right for the gross proceeds of ¥9,678,321 on November 5, 2020. The stock acquisition rights are converted into 1,762,900 common shares and have initial exercise of ¥610 per share and minimum exercise price of ¥305 per share. The expected fund raise through exercise of stock acquisition right are ¥1,085,047,321. The transaction include participation from existing investor Inflexion II Fund L.P., funds managed by Advantage Partners, Inc. for 4,524 stock acquisition rights, Investment Limited Partnership InfleXion II for 11,612 stock acquisition rights and Flagship Asset Management Investment Association No. 90 for 1,493 stock acquisition rights. Ankündigung • Sep 12
CanBas Co., Ltd. to Report Q1, 2021 Results on Nov 13, 2020 CanBas Co., Ltd. announced that they will report Q1, 2021 results on Nov 13, 2020 